UK College of Pharmacy to develop treatments for people exposed to dirty bomb

"As an alumnus of UK and member of the private business sector in Kentucky, I am very excited about working with the College of Pharmacy on this project," said Jeff Lawrence, Ph.D., director of ChemPharma International. "I consider this an excellent opportunity to demonstrate what the combined strengths of the research and academic environment at UK and the technology business sector of Kentucky are able to achieve."

This collaboration among researchers at the university and ChemPharma along with the vital role of the CPST, demonstrates UK's commitment to being a national and international leader in innovative research that has an impact far beyond the Commonwealth, said Kenneth B. Roberts, Ph.D., Dean of the UK College of Pharmacy.

The CPST is an FDA-registered pharmaceutical manufacturing facility utilizing current Good Manufacturing Practices (cGMPs) focusing on formulation and development of pharmaceutical testing methods and the manufacturing of drug products. The CPST will expand in 2006 with the opening of a new 20,000-square-foot facility which will be the largest sterile pharmaceutical manufacturing facility in Kentucky. The new facility, located at the UK Coldstream Research Campus, will play a major role in providing manufacturing services of National Stockpile agents which could lead to greatly expanded employment opportunities.

ChemPharma International provides worldwide research and development services and custom chemical synthesis focused on drug discovery for the pharmaceutical industry. They have collaborated with the CPST during the past two years on a variety of projects; however, this federally funded grant is by far the most significant endeavor with tUK to date.

"ChemPharma views their role in this project as a step towards fulfilling the university's goal of bringing technologically advanced private industry and the university together to create opportunities for Central Kentucky," Lawrence said.


Contact: Louise DuPont
University of Kentucky

Page: 1 2 3

Related biology news :

1. CSHL awarded Pre-College Science Education Grant by HHMI
2. 454 Life Sciences and Baylor College of Medicine complete sequencing of DNA pioneer
3. Nobel laureate James Watson receives personal genome in ceremony at Baylor College of Medicine
4. Hamilton College researchers discover molecules with potential to treat breast cancer
5. AEA, UAlbany College of Nanoscale Science and Engineering to partner on CIRCA 07
6. Granthams to fund Institute for Climate Change at Imperial College London
7. Vet College gets grant to develop fish virus diagnostic technique
8. Rutgers College of Nursing dean authors a book on genetics and how it affects nursing and health
9. Williams College biologist explores photosynthetic apparatus
10. NCI funds Einstein and U. Albany NanoCollege to make worlds smallest cancer detection device
11. American College of Medical Genetics -- 2007 Annual Clinical Genetics Meeting Announcement

Post Your Comments:

(Date:7/2/2020)... ... July 01, 2020 , ... ... phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute ... Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, ... glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its ... are charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... software and software-driven clinical data services that accelerate drug development, is collaborating with ... an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the first ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and ... a great surgery is only the beginning of a successful study, while protecting and ... Join Brad Gien, Global Head of Surgery from Envigo in a ...
(Date:7/18/2020)... ... 2020 , ... Medial EarlySign , a leader in ... high-burden diseases, and Centric Consulting, a business and technology consulting firm, today announced ... in order to identify and prioritize patients for care. , Combining Centric’s management ...
(Date:7/10/2020)... (PRWEB) , ... July 08, 2020 , ... ... services and products, announces a significant expansion of laboratory operations through its ... for agencies implementing testing programs. , Bode-CARES provides a turnkey ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research ... to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic ... MA has been using the zebrafish model to investigate the causes of leukaemia ...
Breaking Biology Technology:
Cached News: